Alternative lengthening of telomeres in mammalian cells

被引:519
作者
Henson, JD [1 ]
Neumann, AA [1 ]
Yeager, TR [1 ]
Reddel, RR [1 ]
机构
[1] Childrens Med Res Inst, Sydney, NSW 2145, Australia
关键词
telomere; alternative lengthening of telomeres; ALT-associated PML bodies; recombination; immortalization; cancer;
D O I
10.1038/sj.onc.1205058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some immortalized mammalian cell lines and tumors maintain or increase the overall length of their telomeres in the absence of telomerase activity by one or more mechanisms referred to as alternative lengthening of telomeres (ALT). Characteristics of human ALT cells include great heterogeneity of telomere size (ranging from undetectable to abnormally long) within individual cells, and ALT-associated PML bodies (APBs) that contain extrachromosomal telomeric DNA, telomere-specific binding proteins, and proteins involved in DNA recombination and replication. Activation of ALT during immortalization involves recessive mutations in genes that are as yet unidentified. Repressors of ALT activity are present in normal cells and some telomerase-positive cells. Telomere length dynamics in ALT cells suggest a recombinational mechanism. Inter-telomeric copying occurs, consistent with a mechanism in which single-stranded DNA at one telomere terminus invades another telomere and uses it as a copy template resulting in net increase in telomeric sequence. It is possible that t-loops, linear and/or circular extrachromosomal telomeric DNA, and the proteins found in APBs, may be involved in the mechanism. ALT and telomerase activity can co-exist within cultured cells, and within tumors. The existence of ALT adds some complexity to proposed uses of telomere-related parameters in cancer diagnosis and prognosis, and poses challenges for the design of anticancer therapeutics designed to inhibit telomere maintenance.
引用
收藏
页码:598 / 610
页数:13
相关论文
共 152 条
  • [81] Linear mitochondrial genomes:: 30 years down the line
    Nosek, J
    Tomáska, L
    Fukuhara, H
    Suyama, Y
    Kovác, L
    [J]. TRENDS IN GENETICS, 1998, 14 (05) : 184 - 188
  • [82] CHROMOSOME-7 SUPPRESSES INDEFINITE DIVISION OF NONTUMORIGENIC IMMORTALIZED HUMAN FIBROBLAST CELL-LINES KMST-6 AND SUSM-1
    OGATA, T
    AYUSAWA, D
    NAMBA, M
    TAKAHASHI, E
    OSHIMURA, M
    OISHI, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) : 6036 - 6043
  • [83] GENETIC COMPLEMENTATION OF THE IMMORTAL PHENOTYPE IN GROUP-D CELL-LINES BY INTRODUCTION OF CHROMOSOME-7
    OGATA, T
    OSHIMURA, M
    NAMBA, M
    FUJII, M
    OISHI, M
    AYUSAWA, D
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (01): : 35 - 40
  • [84] Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity
    Ogino, H
    Nakabayashi, K
    Suzuki, M
    Takahashi, E
    Fujii, M
    Suzuki, T
    Ayusawa, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (02) : 223 - 227
  • [85] TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells
    Okabe, J
    Eguchi, A
    Masago, A
    Hayakawa, T
    Nakanishi, M
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (18) : 2639 - 2650
  • [86] Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension
    Okayasu, I
    Osakabe, T
    Fujiwara, M
    Fukuda, H
    Kato, M
    Oshimura, M
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (10): : 965 - 970
  • [87] Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism
    Opitz, OG
    Suliman, Y
    Hahn, WC
    Harada, H
    Blum, HE
    Rustgi, AK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (05) : 725 - 732
  • [88] Park KH, 1998, INT J ONCOL, V13, P489
  • [89] Park PU, 1999, MOL CELL BIOL, V19, P3848
  • [90] EVIDENCE FOR THE RECESSIVE NATURE OF CELLULAR IMMORTALITY
    PEREIRASMITH, OM
    SMITH, JR
    [J]. SCIENCE, 1983, 221 (4614) : 964 - 966